ABBOTT ALERT: Bragar Eagel Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Abbott Laboratories and Encourages Investors to Contact the Firm
NEW YORK--(BUSINESS WIRE)-- #ABT--Bragar Eagel Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Abbott Laboratories (“Abbott” or the “Company”) (NYSE: ABT) in the United States District Court for the Northern District of Illinois on behalf of all persons and entities who purchased or otherwise acquired Abbott securities between February 19, 2021 and June 8, 2022, both dates inclusive (the “Class Period”). Investors ha
ABBOTT ALERT: Bragar Eagel Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Abbott Laboratories and Encourages Investors to Contact the Firm
NEW YORK--(BUSINESS WIRE)-- #ABT--Bragar Eagel Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Abbott Laboratories (“Abbott” or the “Company”) (NYSE: ABT) in the United States District Court for the Northern District of Illinois on behalf of all persons and entities who purchased or otherwise acquired Abbott securities between February 19, 2021 and June 8, 2022, both dates inclusive (the “Class Period”). Investors ha